FDA Drug Application (206042) for EMTRICITABINE;TENOFOVIR DISOPROXIL FUMARATE;NEVIRAPINE by MYLAN LABS LTD

Back to FDA Applications sponsored by MYLAN LABS LTD

Application Number206042
Product Number001
FormTABLET;ORAL
Dosage200MG;300MG;200MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameEMTRICITABINE;TENOFOVIR DISOPROXIL FUMARATE;NEVIRAPINE
Active IngredientEMTRICITABINE;TENOFOVIR DISOPROXIL FUMARATE;NEVIRAPINE



Back to FDA Applications sponsored by MYLAN LABS LTD

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.